142 related articles for article (PubMed ID: 17893252)
1. The activation of somatostatinergic receptors by either somatostatin-14 or cortistatin-17 often inhibits ACTH hypersecretion in patients with Cushing's disease.
Giordano R; Picu A; Bonelli L; Broglio F; Prodam F; Grottoli S; Muccioli G; Ghigo E; Arvat E
Eur J Endocrinol; 2007 Oct; 157(4):393-8. PubMed ID: 17893252
[TBL] [Abstract][Full Text] [Related]
2. Cortistatin-17 and -14 exert the same endocrine activities as somatostatin in humans.
Gottero C; Prodam F; Destefanis S; Benso A; Gauna C; Me E; Filtri L; Riganti F; Van Der Lely AJ; Ghigo E; Broglio F
Growth Horm IGF Res; 2004 Oct; 14(5):382-7. PubMed ID: 15336231
[TBL] [Abstract][Full Text] [Related]
3. Endocrine activities of cortistatin-14 and its interaction with GHRH and ghrelin in humans.
Broglio F; Arvat E; Benso A; Gottero C; Prodam F; Grottoli S; Papotti M; Muccioli G; van der Lely AJ; Deghenghi R; Ghigo E
J Clin Endocrinol Metab; 2002 Aug; 87(8):3783-90. PubMed ID: 12161511
[TBL] [Abstract][Full Text] [Related]
4. Cortistatin-8, a synthetic cortistatin-derived ghrelin receptor ligand, does not modify the endocrine responses to acylated ghrelin or hexarelin in humans.
Prodam F; Benso A; Gramaglia E; Lucatello B; Riganti F; van der Lely AJ; Deghenghi R; Muccioli G; Ghigo E; Broglio F
Neuropeptides; 2008 Feb; 42(1):89-93. PubMed ID: 18061663
[TBL] [Abstract][Full Text] [Related]
5. Endocrine actions of cortistatin: in vivo studies.
Broglio F; Grottoli S; Arvat E; Ghigo E
Mol Cell Endocrinol; 2008 May; 286(1-2):123-7. PubMed ID: 18281148
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin and somatostatin receptors in Cushing's disease.
Hofland LJ
Mol Cell Endocrinol; 2008 May; 286(1-2):199-205. PubMed ID: 18221833
[TBL] [Abstract][Full Text] [Related]
7. Effects of cortistatin-14 and somatostatin-14 on the endocrine response to hexarelin in humans.
Benso A; Gottero C; Prodam F; Gauna C; Destefanis S; Filtri L; van der Lely AJ; Deghenghi R; Ghigo E; Broglio F
J Endocrinol Invest; 2003 Jul; 26(7):599-603. PubMed ID: 14594107
[TBL] [Abstract][Full Text] [Related]
8. Failure of somatostatin and octreotide to acutely affect the hypothalamic-pituitary-adrenal function in patients with corticotropin hypersecretion.
Ambrosi B; Bochicchio D; Fadin C; Colombo P; Faglia G
J Endocrinol Invest; 1990 Mar; 13(3):257-61. PubMed ID: 1973178
[TBL] [Abstract][Full Text] [Related]
9. Cortistatin-17 and somatostatin-14 display the same effects on growth hormone, prolactin, and insulin secretion in patients with acromegaly or prolactinoma.
Grottoli S; Gasco V; Broglio F; Baldelli R; Ragazzoni F; Gallenca F; Mainolfi A; Prodam F; Muccioli G; Ghigo E
J Clin Endocrinol Metab; 2006 Apr; 91(4):1595-9. PubMed ID: 16449338
[TBL] [Abstract][Full Text] [Related]
10. Role of somatostatin receptors in normal and tumoral pituitary corticotropic cells.
Hofland LJ; Lamberts SW; Feelders RA
Neuroendocrinology; 2010; 92 Suppl 1():11-6. PubMed ID: 20829612
[TBL] [Abstract][Full Text] [Related]
11. Effect of pioglitazone on adrenocorticotropic hormone and cortisol secretion in Cushing's disease.
Suri D; Weiss RE
J Clin Endocrinol Metab; 2005 Mar; 90(3):1340-6. PubMed ID: 15585550
[TBL] [Abstract][Full Text] [Related]
12. Ghrelin secretion is inhibited by either somatostatin or cortistatin in humans.
Broglio F; Koetsveld Pv Pv; Benso A; Gottero C; Prodam F; Papotti M; Muccioli G; Gauna C; Hofland L; Deghenghi R; Arvat E; Van Der Lely AJ; Ghigo E
J Clin Endocrinol Metab; 2002 Oct; 87(10):4829-32. PubMed ID: 12364482
[TBL] [Abstract][Full Text] [Related]
13. Preoperative normalization of cortisol levels in Cushing's disease after medical treatment: consequences for somatostatin and dopamine receptor subtype expression and in vitro response to somatostatin analogs and dopamine agonists.
van der Pas R; Feelders RA; Gatto F; de Bruin C; Pereira AM; van Koetsveld PM; Sprij-Mooij DM; Waaijers AM; Dogan F; Schulz S; Kros JM; Lamberts SW; Hofland LJ
J Clin Endocrinol Metab; 2013 Dec; 98(12):E1880-90. PubMed ID: 24081741
[TBL] [Abstract][Full Text] [Related]
14. The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5.
Hofland LJ; van der Hoek J; Feelders R; van Aken MO; van Koetsveld PM; Waaijers M; Sprij-Mooij D; Bruns C; Weckbecker G; de Herder WW; Beckers A; Lamberts SW
Eur J Endocrinol; 2005 Apr; 152(4):645-54. PubMed ID: 15817922
[TBL] [Abstract][Full Text] [Related]
15. The role of somatostatin analogs in Cushing's disease.
van der Hoek J; Lamberts SW; Hofland LJ
Pituitary; 2004; 7(4):257-64. PubMed ID: 16132202
[TBL] [Abstract][Full Text] [Related]
16. Identification of the receptors for somatostatin (SST) and cortistatin (CST) in chickens and investigation of the roles of cSST28, cSST14, and cCST14 in inhibiting cGHRH1-27NH2-induced growth hormone secretion in cultured chicken pituitary cells.
Meng F; Huang G; Gao S; Li J; Yan Z; Wang Y
Mol Cell Endocrinol; 2014 Mar; 384(1-2):83-95. PubMed ID: 24418361
[TBL] [Abstract][Full Text] [Related]
17. Cortistatin is not a somatostatin analogue but stimulates prolactin release and inhibits GH and ACTH in a gender-dependent fashion: potential role of ghrelin.
Córdoba-Chacón J; Gahete MD; Pozo-Salas AI; Martínez-Fuentes AJ; de Lecea L; Gracia-Navarro F; Kineman RD; Castaño JP; Luque RM
Endocrinology; 2011 Dec; 152(12):4800-12. PubMed ID: 21971153
[TBL] [Abstract][Full Text] [Related]
18. Ghrelin does not mediate the somatotroph and corticotroph responses to the stimulatory effect of glucagon or insulin-induced hypoglycaemia in humans.
Broglio F; Prodam F; Gottero C; Destefanis S; Me E; Riganti F; Giordano R; Picu A; Balbo M; Van der Lely AJ; Ghigo E; Arvat E
Clin Endocrinol (Oxf); 2004 Jun; 60(6):699-704. PubMed ID: 15163333
[TBL] [Abstract][Full Text] [Related]
19. Cortistatin modulates the expression and release of corticotrophin releasing hormone in rat brain. Comparison with somatostatin and octreotide.
Tringali G; Greco MC; Lisi L; Pozzoli G; Navarra P
Peptides; 2012 Apr; 34(2):353-9. PubMed ID: 22342595
[TBL] [Abstract][Full Text] [Related]
20. Effects of loperamide on the human hypothalamo-pituitary-adrenal axis in vivo and in vitro.
Auernhammer CJ; Stalla GK; Lange M; Pfeiffer A; Müller OA
J Clin Endocrinol Metab; 1992 Aug; 75(2):552-7. PubMed ID: 1322429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
